West Virginia IDEA-CTR

西弗吉尼亚州 IDEA-CTR

• 批准号: 8339639
• 负责人: Sally Lynn Hodder
• 金额: $ 1958.19万
• 依托单位: WEST VIRGINIA UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-15 至 2017-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8339639
• 关键词: Accountability; Address; Appalachian Region; Area; Award; Biometry; Cardiovascular system; Clinical; Clinical Informatics; Clinical Research; Clinical Sciences; Clinical and Translational Science Awards; Communities; Ensure; Extramural Activities; Faculty; Funding; Funding Mechanisms; Goals; Health; Health Policy; Health Sciences; Health system; Healthcare; Home environment; Indiana; Institutes; Institution; Kentucky; Malignant Neoplasms; Medical center; Mentors; Obesity associated disease; Ohio; Osteopathic Medicine; Positioning Attribute; Process; Productivity; Program Evaluation; Public Health; Research; Research Infrastructure; Research Institute; Research Personnel; Research Support; Resources; Schools; Science; Scientist; Stroke; Training; Translational Research; Translations; Universities; West Virginia; catalyst; clinical care; health disparity; human subject protection; innovation; programs; public health relevance

DESCRIPTION (provided by applicant): The goal of the West Virginia Clinical and Translation Science Institute's (WVCTSI) IDeA-CTR application is to expand our infrastructure for, and practice of, clinical and translational research to a level competitive for a Clinical and Translational Science Award (CTSA). To this end, the WVCTSI was established in 2008 as the organizational home supporting research to address the health and healthcare needs of the people of West Virginia and Central Appalachia, and ultimately to eliminate health disparities. To realize our ambitious goal, the WVCTSI, which includes West Virginia University, Charleston Area Medical Center, West Virginia School of Osteopathic Medicine, and West Virginia United Health Systems, has partnered with the Appalachian Translational Research Institute, which was founded by our IDeA state partner and CTSA recipient the University of Kentucky. The WVCTSI will achieve its goal through pursuit of three aims: 1) Grow the WVCTSI as an academic home and a catalyst for clinical and translational research that targets cancer, cardiovascular-stroke, and obesity related diseases; 2) Establish cross cutting research partnerships among the WVCTSI partnered institutions and collaborating CTSAs at University of Kentucky, Ohio State University, and Indiana University to increase our research capacity; and 3) Utilize innovative recruitment, training, and mentoring strategies to develop clinical and translational scientists at each of the WVCTSI institutions. These aims are addressed through recruitment and support of clinical and translational scientists and a broad educational and mentoring program. In addition, participating faculty are provided with research resources that include biostatistics, clinical informatics, and access to a range of pilot funding mechanisms. Furthermore, mechanisms to streamline regulatory processes without compromising human subject protections and to engage communities fully in the research agenda are being developed. Finally, to ensure accountability and quality improvement, a robust evaluation program has been established. Overall, the WVCTSI has developed a strong infrastructure to increase the number of extramural funded clinical and translational researchers and has a well-considered plan for enhancing capacity and productivity over the next five years, positioning us for competitiveness for a CTSA.

描述（由申请人提供）：西弗吉尼亚州临床和翻译科学研究所（WVCTSI）的IDEA-CTR申请的目标是将我们的临床和翻译研究基础设施和实践扩展到临床和翻译科学奖（CTSA）的竞争水平。为此，WVCTSI成立于2008年，作为支持研究的组织之家，以解决西弗吉尼亚州和阿巴拉契亚中部人民的健康和医疗保健需求，并最终消除健康差距。为了实现我们雄心勃勃的目标，WVCTSI，其中包括西弗吉尼亚大学，查尔斯顿地区医疗中心，骨科医学西弗吉尼亚学校，和西弗吉尼亚联合卫生系统，已与阿巴拉契亚转化研究所，这是由我们的IDEA国家合作伙伴和CTSA收件人肯塔基州大学成立。WVCTSI将通过追求三个目标来实现其目标：1）将WVCTSI发展成为一个学术之家，并成为针对癌症、心血管中风和肥胖相关疾病的临床和转化研究的催化剂; 2）在WVCTSI合作机构之间建立跨领域研究伙伴关系，并在肯塔基州大学、俄亥俄州州立大学和印第安纳州大学建立合作CTSA，以提高我们的研究能力;和3）利用创新的招聘，培训和指导战略，以发展临床和转化科学家在每个WVCTSI机构。这些目标是通过招募和支持临床和转化科学家以及广泛的教育和指导计划来实现的。此外，参与教师提供研究资源，包括生物统计学，临床信息学，并获得一系列试点资金机制。此外，正在制定机制，以简化监管程序，同时不损害对人类受试者的保护，并使社区充分参与研究议程。最后，为了确保问责制和质量改进，制定了一个强有力的评价方案。总的来说，WVCTSI已经建立了强大的基础设施，以增加校外资助的临床和翻译研究人员的数量，并制定了一个经过深思熟虑的计划，以提高未来五年的能力和生产力，使我们成为CTSA的竞争力。